Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase NA 1Phase 2/3 1Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1058Neoplasms 884Prostatic Neoplasms 510Lung Neoplasms 425Colorectal Neoplasms 359Motor Activity 226Head and Neck Neoplasms 195Uterine Cervical Neoplasms 192Carcinoma, Non-Small-Cell Lung 182Brain Neoplasms 175Pancreatic Neoplasms 162Ovarian Neoplasms 141Colonic Neoplasms 138Carcinoma, Hepatocellular 137Anxiety Disorders 124Rectal Neoplasms 119Hematologic Neoplasms 116Multiple Myeloma 109Stomach Neoplasms 104Neoplasm Metastasis 100Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Melanoma 93Depression 93Urinary Bladder Neoplasms 88Pain 88Glioblastoma 87Endometrial Neoplasms 87Lymphoma 84Disease 84Sarcoma 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Camurati-Engelmann Syndrome × 1 year × Clear all
NCT05209776 2026-06-01

LI-ARVC

University Hospital, Toulouse

Phase NA Recruiting
80 enrolled

Camurati-Engelmann Syndrome, Inflammation, Arrhythmogenic Right Ventricular Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡